STOCK TITAN

iQIYI (IQ) Chief Content Officer restructures major option grants and extends expiries

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

iQIYI, Inc.’s Chief Content Officer Wang Xiaohui reported a series of option transactions that effectively amend existing equity awards rather than open-market trades. The filing shows cancellation of previously outstanding options covering 7,500,000 Class A ordinary shares and issuance of new options for the same number of shares at an exercise price of $0.5119 per share, with the expiration date extended to 10/18/2030. A similar amendment occurs for options over 1,531,250 shares, also moving their expiration to 10/18/2030. Footnotes explain that these options vest over four years starting from 05/11/2026, while earlier grants referenced in the filing have already fully vested. After these changes, Wang continues to hold significant unexercised options, including positions tied to 2,450,000 and 2,275,000 underlying shares that now expire in 2036, underscoring that this Form 4 reflects compensation-related adjustments rather than a change in share ownership.

Positive

  • None.

Negative

  • None.
Insider Wang Xiaohui
Role Chief Content Officer
Type Security Shares Price Value
Disposition Option (right to buy) 1,531,250 $0.00 --
Grant/Award Option (right to buy) 1,531,250 $0.00 --
Disposition Option (right to buy) 7,500,000 $0.00 --
Grant/Award Option (right to buy) 7,500,000 $0.00 --
holding Option (right to buy) -- -- --
holding Option (right to buy) -- -- --
Holdings After Transaction: Option (right to buy) — 0 shares (Direct, null)
Footnotes (1)
  1. The options vest over a four-year period, with 25% vesting on the 1st anniversary of 05/11/2026, and the remaining 75% vesting in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.
Amended option grant 7,500,000 options at $0.5119 Expiration extended to October 18, 2030
Second amended option block 1,531,250 options at $0.5119 Expiration extended to October 18, 2030
Remaining zero-price options 2,450,000 underlying shares Exercise price $0.0000, expire 2036-05-11
Remaining $0.5119 options 2,275,000 underlying shares Exercise price $0.5119, expire 2036-05-11
Four-year vesting start 05/11/2026 New options vest 25% at first anniversary, remainder over 3 years
Fully vested legacy grant 1 Vesting began 02/14/2017 25% at first anniversary, 75% in 12 quarterly installments
Fully vested legacy grant 2 Vesting began 02/28/2018 25% at first anniversary, 75% in 12 quarterly installments
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
Disposition to issuer financial
"transaction_code_description": "Disposition to issuer""
vest over a four-year period financial
"The options vest over a four-year period, with 25% vesting on the 1st anniversary"
expiration date financial
"As amended, the options expire on 10/18/2030."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Option (right to buy financial
"security_title": "Option (right to buy)""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wang Xiaohui

(Last)(First)(Middle)
4F, IQIYI YOUTH CENTER, YOOLEE PLAZA
NO.21 NORTH ROAD OF WORKERS' STADIUM

(Street)
BEIJINGCHINA100027

(City)(State)(Zip)

CHINA

(Country)
2. Issuer Name and Ticker or Trading Symbol
iQIYI, Inc. [ IQ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Content Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option (right to buy)$0.5119 (1)05/11/2036Class A ordinary share2,275,0002,275,000D
Option (right to buy)$0 (2)05/11/2036Class A ordinary share2,450,0002,450,000D
Option (right to buy)$0.511905/11/2026D1,531,250 (3)02/14/2027Class A ordinary share1,531,250(4)0D
Option (right to buy)$0.511905/11/2026A1,531,250 (3)10/18/2030Class A ordinary share1,531,250(4)1,531,250D
Option (right to buy)$0.511905/11/2026D7,500,000 (5)02/28/2028Class A ordinary share7,500,000(6)0D
Option (right to buy)$0.511905/11/2026A7,500,000 (5)10/18/2030Class A ordinary share7,500,000(6)7,500,000D
Explanation of Responses:
1. The options vest over a four-year period, with 25% vesting on the 1st anniversary of 05/11/2026, and the remaining 75% vesting in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
2. The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026.
3. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
4. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030.
5. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
6. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.
/s/ Wang Xiaohui05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did iQIYI (IQ) executive Wang Xiaohui report in this Form 4?

Wang Xiaohui reported amendments to stock options, not stock trades. The filing shows cancellations and regrants of options over 7,500,000 and 1,531,250 Class A shares, extending expiration dates while keeping the same exercise price and compensation nature.

How many iQIYI options were amended for Wang Xiaohui in this filing?

The filing reflects options over 7,500,000 and 1,531,250 Class A ordinary shares being effectively cancelled and regranted. Footnotes describe these as amendments to extend expiration dates, rather than new cash purchases or market sales of iQIYI stock.

What is the exercise price of Wang Xiaohui’s amended iQIYI stock options?

The amended options carry an exercise price of $0.5119 per Class A ordinary share. This price applies to both the 7,500,000-share and 1,531,250-share option blocks that were treated as cancellations and new grants with extended expiration dates.

When do Wang Xiaohui’s amended iQIYI options vest and expire?

Footnotes state the options vest over four years from 05/11/2026, with 25% vesting on the first anniversary and the rest in quarterly or annual installments. The amended grants now expire on 10/18/2030, extending prior 2027 and 2028 expiration dates.

Does this iQIYI Form 4 show Wang Xiaohui buying or selling shares on the market?

The Form 4 does not show open-market buying or selling of iQIYI shares. Instead, it records compensation-related option grants and dispositions to the issuer, reflecting amendments to option terms rather than direct stock transactions with public investors.

What option positions does Wang Xiaohui retain after these iQIYI transactions?

After these transactions, derivative summaries show remaining options tied to 2,450,000 underlying shares at a zero exercise price and 2,275,000 shares at $0.5119. Both blocks now carry expiration dates in 2036, indicating substantial continuing equity incentives.